Cognizant CTSH · NASDAQ
$66.03 +0.40% (+$0.26)
Summary
70 / 100 · Bulios Score
What speaks for it
- You pay 13.4 USD for 1 USD of yearly profit, little for its sector.
- It bought back its own shares for $1.38B in the last fiscal year, 4.6% of its market value.
- It has raised its dividend 6 years in a row and pays out only 26% of profit.
What to watch
- Revenue grew by only 2.8% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.4 USD for 1 USD of yearly profit. Over the last five years it was 17.6 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 4.9% a year over 5 years. Over the last 3 years it grew by 2.8% a year. For the next fiscal year analysts expect revenue to grow by 5.1%. Earnings per share grew by 1.0% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 68 USD
- Sales and administration 16 USD
- Taxes and other 5.5 USD
- Net profit 10 USD
Net profit, industry median (Information Technology Services) 6.2 USD
Out of every 100 USD of revenue, 10 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 1.97%
- Paid out of profit
- 26%
- Raised in a row
- 6 years
You receive $1.30 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 23
- Hold 23
- Sell 5
Today's price within the analysts' price targets
The average target of $64.25 is 2.7% below today's price. 45% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Healthcare Segment 30%
- Financial Services 29%
- Products and Resources 25%
- Communication, Media and Technology 16%
By region
- North America 75%
- Europe 19%
- Other Regions 6.2%
Healthcare Segment brings in 30% of revenue. Products and Resources grew fastest, by 5.4% a year.
Segments in detail